Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -50.09% is 15% above its 5-year average of -58.64%, near the high end of its 5-year range (-138.48%–-30.89%).
As of the fiscal period ended Tuesday, June 30, 2026. 29.25% above its 12-month average of -70.80%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -50.09%.
RETURN ON INVESTED CAPITAL (ROIC)
-50.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-70.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-67.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-58.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+29.25%
CURRENT VS 3Y AVG
+26.30%
CURRENT VS 5Y AVG
+14.58%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.98%
median of 702 covered companies
CURRENT VS SECTOR MEDIAN
-47.40%
vs the sector median at left
Cogent Biosciences, Inc.
Market Cap
$5.24B
Return on Invested Capital (ROIC)
-50.09%
TTM Avg
-70.80%
3Y Avg
-67.97%
5Y Avg
-58.64%
Market Cap
$5.22B
Return on Invested Capital (ROIC)
-21.12%
TTM Avg
-24.05%
3Y Avg
-22.50%
5Y Avg
-16.04%
Market Cap
$5.16B
Return on Invested Capital (ROIC)
-90.04%
TTM Avg
-83.71%
3Y Avg
-67.61%
5Y Avg
-57.95%
Market Cap
$5.32B
Return on Invested Capital (ROIC)
15.35%
TTM Avg
17.38%
3Y Avg
14.85%
5Y Avg
17.21%
Market Cap
$5.35B
Return on Invested Capital (ROIC)
4.59%
TTM Avg
5.84%
3Y Avg
-12.63%
5Y Avg
-15.96%
Market Cap
$5.09B
Return on Invested Capital (ROIC)
5.80%
TTM Avg
5.65%
3Y Avg
5.40%
5Y Avg
4.23%
Market Cap
$5.08B
Return on Invested Capital (ROIC)
-38.03%
TTM Avg
-36.93%
3Y Avg
-41.32%
5Y Avg
-48.18%
Market Cap
$5.51B
Return on Invested Capital (ROIC)
1.41%
TTM Avg
2.38%
3Y Avg
2.50%
5Y Avg
2.69%
Market Cap
$5.55B
Return on Invested Capital (ROIC)
0.43%
TTM Avg
-2.29%
3Y Avg
-2.17%
5Y Avg
-2.17%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | $5.24B | -50.09% | -70.80% | -67.97% | -58.64% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.22B | -21.12% | -24.05% | -22.50% | -16.04% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.16B | -90.04% | -83.71% | -67.61% | -57.95% |
| Doximity, Inc. (DOCS)vs › | $5.32B | 15.35% | 17.38% | 14.85% | 17.21% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.35B | 4.59% | 5.84% | -12.63% | -15.96% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.09B | 5.80% | 5.65% | 5.40% | 4.23% |
| Erasca, Inc. (ERAS)vs › | $5.08B | -38.03% | -36.93% | -41.32% | -48.18% |
| RadNet, Inc. (RDNT)vs › | $5.51B | 1.41% | 2.38% | 2.50% | 2.69% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.55B | 0.43% | -2.29% | -2.17% | -2.17% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.89B | -13.09% | -9.79% | -21.15% | -33.38% |
ROIC
-50.1%
ROE
-70.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -50.09% |
| 2026-03-31 | -42.77% |
| 2025-12-31 | -38.09% |
| 2025-09-30 | -84.58% |
| 2025-06-30 | -138.48% |
| 2025-03-31 | -123.02% |
| 2024-12-31 | -101.38% |
| 2024-09-30 | -78.69% |
| 2024-06-30 | -62.73% |
| 2024-03-31 | -51.73% |
| 2023-12-31 | -75.61% |
| 2023-09-30 | -60.38% |
| 2023-06-30 | -46.61% |
| 2023-03-31 | -65.95% |
| 2022-12-31 | -53.96% |
| 2022-09-30 | -42.12% |
| 2022-06-30 | -33.31% |
| 2022-03-31 | -49.83% |
| 2021-12-31 | -35.14% |
| 2021-09-30 | -30.89% |
| 2021-06-30 | -45.96% |
| 2021-03-31 | -38.74% |
| 2020-12-31 | -34.56% |
| 2020-09-30 | -57.21% |
| 2020-06-30 | -102.43% |
| 2020-03-31 | -89.18% |
| 2019-12-31 | -88.95% |
| 2019-09-30 | -129.80% |
| 2019-06-30 | -93.25% |
| 2019-03-31 | -72.39% |
| 2018-12-31 | -59.04% |
| 2018-09-30 | -49.53% |
| 2018-06-30 | -39.12% |
| 2018-03-31 | -132.33% |
| 2017-12-31 | -68.96% |
